Rapid Micro Biosystems (RPID) Preferred Dividend Payments (2020 - 2021)
Rapid Micro Biosystems (RPID) reported Preferred Dividend Payments of -$986000.0 for Q4 2021, down 169.88% on a YoY basis from $1.4 million in Q4 2020, and down 369.52% sequentially from -$210000.0 in Q3 2021.
Rapid Micro Biosystems (RPID) Preferred Dividend Payments (2020 - 2021) Analysis & Trends
Rapid Micro Biosystems (RPID) has 2 years of Preferred Dividend Payments data on file, last reported at -$986000.0 in Q4 2021.
- For the quarter ending Q4 2021, Preferred Dividend Payments fell 169.88% year-over-year to -$986000.0; the trailing twelve-month figure through Dec 2022 stood at -$1.2 million (down 254.32% YoY), and the FY2021 full-year result was $1.8 million, down 59.96% from the prior year.
- Preferred Dividend Payments retreated to -$986000.0 in Q4 2021, from -$210000.0 in the prior quarter.
- In the past five years, Preferred Dividend Payments ranged from a high of $1.4 million in Q4 2020 to a low of -$986000.0 in Q4 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.89 Bn | 173.59 Bn | 6.27 Bn | - |
| 2 | Stryker | 127.82 Bn | 124.94 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.49 Bn | 98.27 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.24 Bn | 65.78 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.02 Bn | 44.34 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.25 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.17 Bn | 25.89 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.72 Bn | 26.14 Bn | - | - |
| 9 | Koninklijke Philips | 25.31 Bn | 22.19 Bn | 2.07 Bn | - |
| 10 | Rapid Micro Biosystems | 89.96 Mn | 80.52 Mn | 371,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -986,000.00 |
| Sep 30, 2021 | -210,000.00 |
| Jun 30, 2021 | 1.18 Mn |
| Mar 31, 2021 | 787,000.00 |
| Dec 31, 2020 | 1.41 Mn |
| Sep 30, 2020 | 832,000.00 |
| Jun 30, 2020 | 1.23 Mn |